期刊文献+

2011~2015年医院呼吸内科常见革兰阴性菌耐药性分析与临床用药探讨 被引量:1

The characteristics of drug resistance and clinical medication of Gram-negative bacteria in hospital during 2011~2015
下载PDF
导出
摘要 目的 分析2011-2015年我院呼吸内科常见革兰阴性菌的分布情况及耐药性特点,为规范抗生素的合理使用提供依据。方法 选用法国梅里埃公司生产的ID 32GD试剂盒,应用ATB Expression全自动分析系统对细菌进行鉴定与药敏试验。结果 2011-2015年在我院呼吸内科常见的病原菌分别为肺炎克雷伯菌(31.0%)、大肠埃希菌(21.2%)、铜绿假单胞菌(23.2%)与鲍曼不动杆菌(14.8%)。肺炎克雷伯菌对碳青霉烯类的耐药率几乎为0,对单纯的头孢菌素耐药率相对较高,但对含β-内酰胺酶抑制剂的头孢菌素类以及阿米卡星有较强的抗菌活性;大肠埃希菌对哌拉西林耐药率高,但对含酶青霉素类有较强的抗菌活性,对碳青霉烯类的耐药率连续5年来均为零;铜绿假单胞菌对磺胺类耐药性较高,对头孢三代、头孢四代及含酶青霉素类与含酶头孢类均有较强的抗菌活性,但敏感性呈逐年下降趋势;鲍曼不动杆菌的耐药率呈逐年上升趋势,仅对含酶的头孢哌酮/舒巴坦敏感(约80%)。结论 医院呼吸内科革兰阴性菌仍以肺炎克雷伯菌、大肠埃希菌、铜绿假单胞菌、鲍曼不动杆菌为主。鲍曼不动杆菌耐药性逐年增长的问题已日趋严重,相关部门应定期监测细菌耐药趋势,指导临床合理用药,特别是合理应用抗生素以避免细菌耐药及减少细菌耐药性的发生。 Objective To analyze the distribution and drug resistance of gram negative bacteria in the respiratory department of our hospital during 2011-2015,and to provide the help for clinical treatment. Methods The ID 32GD kit produced by French bioMerieux ATB, Expression automatic analysis system for identification and drug sensitivity test of bacteria. Results 2011-2015 years in the Department of respiratory infection in our hospital collected a total of 999 strains of gram negative bacteria,the most common pathogens were Klebsiella pneumoniae, accounting for 31%, followed by Escherichia coli, accounting for 21.2 %, again were Pseudomonas aeruginosa and Acinetobacter Bauman, the the ratio were 23.2% and 14.8 %. Klebsiella pneumoniae resistant to carbopenems rate is almost zero,the relatively high rate of cephalosporin resistant herpes,but of cephalosporin containing beta lactamase inhibitors will maintain strong antibacterial activity, Amikacin also maintained a strong antibacterial activity. Escherichia coli resistant to piperacillin rate is very high,but has strong antibacterial activity of enzyme containing penicillins,quinolones and sulfonamides were higher on the resistance rate,low rate of resistance to Amikacin, resistance to carbapenems was very low,for 5 consecutive years,the resistance rate to zero. Pseudomonas aeruginosa of sulfonamides has almost no effect,the three generation, four generation of eephalosporin and enzyme containing penicillins and cephalosporins containing enzymes have strong antibacterial activity of aminoglycosides can maintain high antibacterial activity,maintain a high activity is no exception to carbapenems, but the sensitivity is decreased year by year. Bauman Acinetobaeter resistance rate is increasing year by year,in addition to enzyme containing Cef- operazone/Shubatan is about 20%, especially aztreonam, drug resistance rate for three consecutive years up to 100M,even resistant to carbapenems was as high as 78.6%. Conclusion Hospital Department of respiratory medicine gram negative bacteria are still Klebsiella pneumoniae,Escherichia coli,Pseudomonas aeruginosa, Acinetobatter Bauman dominated. In clinical work, we need to guard against the growth of drug resistance of Acinetobacter Bauman, we should regularly monitor the trend of bacterial drug resistance, rational use of antibiotics in order to reduce the occurrence of bacterial drug resistance.
出处 《蛇志》 2016年第4期399-402,共4页 Journal of Snake
基金 广西自然科学基金项目(编号:2012GXNSFAA276011) 广西卫生厅课题(编号:Z2012079) 广西急诊与医学救援人才小高地课题(编号:GXJZ201512) 广西高校中青年教师基础能力提升项目课题(编号:KY2016YB099)
关键词 呼吸内科 革兰阴性菌 耐药性 临床用药 Department of respiratory medicine Gram negative bacteria Drug resistance Clinical drug use
  • 相关文献

参考文献3

  • 1胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 2陈华彬,王冬国,王红戟,戚永孝.多药耐药铜绿假单胞菌耐药基因的研究[J].中华医院感染学杂志,2013,23(3):488-491. 被引量:20
  • 3汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:465

二级参考文献35

  • 1翁幸鐾,糜祖煌,金辉.多重耐药大肠埃希菌获得性耐药基因检测及指标聚类分析[J].中华临床感染病杂志,2011,4(3). 被引量:29
  • 2黄支密,单浩,郭满盈,陈榆,仵蕾,糜祖煌,诸葛青云,秦玲.多重耐药铜绿假单胞菌耐药基因及亲缘性分析[J].中华医院感染学杂志,2007,17(4):366-369. 被引量:22
  • 3Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 5Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 6Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 7Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 8Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 9Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 10CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).

共引文献896

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部